Product Information
FELBATOL 400 MG TABLET is a brand product labeled by Viatris Specialty LLC, priced at $14.6851 per EA under NDC 00037043001. Its NADAC has been published 362 times since Nov 28, 2013.
FDA first approved this application on Jul 29, 1993. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the felbamate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
400 mg/1
Manufacturer
Viatris Specialty LLCNDC
00037043001
Classification
Brand
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
FELBAMATEApproval Type
New Drug (NDA)
FDA Application
NDA020189FDA Approved
7/29/1993
TE Code
AB
On Market Since
7/29/1993
Pharmacological Classes
Price Statistics
The NADAC for FELBATOL 400 MG TABLET has been published 362 times since Nov 28, 2013, and over the history we have for it it has risen 178.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $14.6851 per EA |
|---|---|
| All-time high | $14.8275 (Oct 15, 2025) |
| All-time low | $5.2811 (Nov 28, 2013) |
| 52-week high | $14.8275 |
| 52-week low | $14.6851 |
| Median price | $12.4174 |
| Average price | $11.4122 |
| Largest weekly change | +50.0% (Oct 8, 2014) |
| Weeks tracked | 362 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the felbamate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Viatris Specialty LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
felbamate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Anti-epileptic Agent class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of FELBATOL 400 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for FELBATOL 400 MG TABLET, manufactured by Viatris Specialty LLC, is $14.6851 per EA (NDC 00037043001), effective Sep 30, 2026.
How has the price of FELBATOL 400 MG TABLET changed over time?
Over the history we have for it, the NADAC for FELBATOL 400 MG TABLET has risen 178.1%. It has been tracked across 362 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for FELBATOL 400 MG TABLET?
Since Nov 28, 2013, the NADAC for FELBATOL 400 MG TABLET has ranged from a low of $5.2811 (Nov 28, 2013) to a high of $14.8275 (Oct 15, 2025), with a median of $12.4174 per EA.
Are there cheaper alternatives to FELBATOL 400 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of FELBATOL 400 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures FELBATOL 400 MG TABLET?
FELBATOL 400 MG TABLET (NDC 00037043001) is labeled by Viatris Specialty LLC, and CMS classifies it as a brand product.